PKCθ utility in diagnosing c-KIT/DOG-1 double negative gastrointestinal stromal tumors.

BACKGROUND The aim of this study was to evaluate the diagnosis value of an immunohistochemical (IHC) panel of three antibodies for the diagnosis of gastrointestinal stromal tumors (GISTs). MATERIAL AND METHODS In 80 consecutive GISTs without lymph node metastases, the IHC examinations were performed using the antibodies CD117 (c-KIT), DOG-1 and c-theta (PKCθ) protein. The diagnostic value of PKCθ in c-KIT/DOG-1 negative GISTs has been explored in fewer than 10 Medline-indexed papers. RESULTS The c-KIT, PKCθ and DOG-1 positivity was noted in 92.50% (n = 74), 90% (n = 72) and 76.25% (n = 61) of the cases, respectively. All of the C-KIT negative cases (n = 6) were also DOG-1 negative but displayed PKCθ positivity. All of the DOG-1 positive cases (n = 61) also expressed c-KIT. No correlation between the examined markers and clinicopathological parameters was noted. CONCLUSIONS The PKCθ sensitivity is similar to c-KIT and superior to DOG-1 sensitivity. All of the c-KIT/DOG-1 negative GISTs seem to express PKCθ. For a proper diagnosis of GIST, the c-KIT/DOG-1/PKCθ panel should be used, with possible therapeutic but not prognostic value.

[1]  A. Musarò,et al.  Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy , 2017, EBioMedicine.

[2]  D. Neureiter,et al.  Back to the start: Evaluation of prognostic markers in gastrointestinal stromal tumors. , 2016, Molecular and clinical oncology.

[3]  K. Søreide,et al.  Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. , 2016, Cancer epidemiology.

[4]  S. Gurzu,et al.  Unexpected maspin immunoreactivity in Merkel cell carcinoma , 2015, Diagnostic Pathology.

[5]  Chun-wei Xu,et al.  Diagnosis value of CD117 and PDGFRA, alone or in combination DOG1, as biomarkers for gastrointestinal stromal tumors. , 2015, Annals of translational medicine.

[6]  Seiichi Hirota,et al.  The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines , 2015, Gastric Cancer.

[7]  M. Stack,et al.  An Update on Immunohistochemistry in Translational Cancer Research , 2015 .

[8]  S. Gurzu,et al.  Relationship of endothelial area with VEGF-A, COX-2, maspin, c-KIT, and DOG-1 immunoreactivity in liposarcomas versus non-lipomatous soft tissue tumors. , 2015, International journal of clinical and experimental pathology.

[9]  S. Gurzu,et al.  Correlation of angiogenesis with other immunohistochemical markers in cutaneous basal and squamous cell carcinomas. , 2015, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[10]  Heikki Joensuu,et al.  Gastrointestinal stromal tumour , 2013, The Lancet.

[11]  M. Jin,et al.  Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours , 2013, Scandinavian journal of gastroenterology.

[12]  R. Reis,et al.  Involvement of signaling molecules in the prediction of response to imatinib treatment in metastatic GIST patients. , 2012, The Journal of surgical research.

[13]  Se Jin Park,et al.  Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases. , 2012, Anticancer research.

[14]  M. Mora,et al.  Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers? , 2012, Pathology, research and practice.

[15]  Y. Kang,et al.  Clinicopathological and immunohistochemical features of gastointestinal stromal tumors. , 2010, Cancer research and treatment : official journal of Korean Cancer Association.

[16]  W. Young,et al.  Gastric Stromal Tumors in Carney Triad Are Different Clinically, Pathologically, and Behaviorally From Sporadic Gastric Gastrointestinal Stromal Tumors: Findings in 104 Cases , 2010, The American journal of surgical pathology.

[17]  J. Lasota,et al.  DOG1 Antibody in the Differential Diagnosis of Gastrointestinal Stromal Tumors: A Study of 1840 Cases , 2009, The American journal of surgical pathology.

[18]  C. Corless,et al.  Monoclonal Antibody DOG1.1 Shows Higher Sensitivity Than KIT in the Diagnosis of Gastrointestinal Stromal Tumors, Including Unusual Subtypes , 2009, The American journal of surgical pathology.

[19]  H. Joensuu.  Risk stratification of patients diagnosed with gastrointestinal stromal tumor. , 2008, Human pathology.

[20]  W. H. Kim,et al.  Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining , 2007, Journal of Clinical Pathology.

[21]  J. Fletcher,et al.  KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance , 2007, Oncogene.

[22]  C. Park,et al.  PKCtheta expression in gastrointestinal stromal tumor. , 2006, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[23]  T. Nakajima,et al.  PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT‐negative tumors , 2005, Pathology international.

[24]  E. Campo,et al.  Protein Kinase C θ Is Highly Expressed in Gastrointestinal Stromal Tumors But Not in Other Mesenchymal Neoplasias , 2004, Clinical Cancer Research.

[25]  J. Fletcher,et al.  Protein Kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs). , 2004, Cancer research.

[26]  L. Sobin,et al.  Diagnosis of gastrointestinal stromal tumors: A consensus approach. , 2002, Human pathology.

[27]  T. Gant,et al.  Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes alpha and theta. , 2001, European journal of biochemistry.